- January 8th, 2015
- Author: Maria Mcleod
- Category: Uncategorised
RESPONSE Trial – A randomised, double blind, multi-center, placebo-controlled study to evaluate the efficacy, safety, and tolerability of NT100 in pregnant women with a history of unexplained recurrent pregnancy loss
Are you somebody who is :
- Between 18 and 37 years of age
- Have had 3 or more unexplained miscarriages
- These miscarriages may or may not have happened consecutively (in a row)
Written By: Communications Team
For further information on this story or any other news item, please contact our Communications Team on 0121 472 6984 during normal working hours (Monday to Friday 0800 – 1600) or email them at [email protected].
